News
Fuel Tech to Present at the 22nd Annual H.C. Wainwright Global Investment Conference
Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering solutions for the optimization of combustion systems, emissions control and water treatment in utility and
Genprex Appoints William E. Gannon, Jr., MD, MBA, as Vice President of Regulatory Affairs
Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today
Mannatech Declares Increased Second Quarter 2020 Dividend
Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, announced that its Board of Directors declared a cash dividend
Ammendments to ProtoKinetix AAGP® Protocol for Continuation of Phase 1 Human Trials Have Been Approved by Health Canada
ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB: PKTX), a clinical-stage biomedical company, today announced that Dr. James Shapiro has received approval
Broadway Financial Corporation and CFBanc Corporation to Combine to Create the Largest Black-Led Minority Depository Institution in the U.S.
CFBanc Corporation (“City First”) in Washington, DC and Broadway Financial Corporation (“Broadway,” Nasdaq: BYFC) in Los Angeles, CA announced today that they have entered into a transformational
Genprex to Present at The LD 500 Virtual Conference
Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today
Mannatech Concludes Virtual Worldwide Convention
Mannatech, Incorporated (NASDAQ: MTEX) recently concluded their largest virtual live event in the company's 27-year history. In lieu of helping keep attendees safe from the growing COVID-19
Mannatech Announces Share Repurchase Program
Mannatech, Incorporated (NASDAQ: MTEX), today announced that its Board of Directors has approved a share repurchase program to acquire up to $1.0 million of its outstanding common stock. The
1347 Property Insurance Holdings, Inc. Reports Second Quarter 2020 Financial Results
1347 Property Insurance Holdings, Inc. (Nasdaq: PIH) (the “Company”), a holding company which is implementing business plans to operate as a diversified holding company of reinsurance and
ProtoKinetix AAGP® Moves to Whole Organ Transplantation Testing
ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB: PKTX), a clinical-stage biomedical company, today announced that due to the results that AAGP® has
Fuel Tech Reports 2020 Second Quarter Financial Results
Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering solutions for the optimization of combustion systems, emissions control and water treatment in utility and
Mannatech Reports Second Quarter 2020 Financial Results
Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its second quarter of
Fuel Tech Schedules Second Quarter 2020 Financial Results and Conference Call
Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering solutions for the optimization of combustion systems, emissions control and water treatment in utility and
Nonvoice Partners With Bango to Accelerate 5G App Adoption
Bango (AIM: BGO), the mobile commerce company, announces that it has entered a Bango Marketplace partnership agreement with Nonvoice, the leading 5G app agency. Through the partnership, Nonvoice
Dover Motorsports, Inc. Announces Appointment of Radcliffe Hastings and Michael Tatoian to Its Board of Directors
Dover Motorsports, Inc. (NYSE: DVD) announced that the Board of Directors of the Company, at its regularly scheduled quarterly meeting, appointed Radcliffe Hastings and Michael Tatoian, as
Genprex to Present at Proactive’s One2One Virtual Investor Forum on August 4, 2020
Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, announced
Genprex CEO Participates in a Second-Round Live Interview on the “Big Biz Show”
Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today
Dover Motorsports, Inc. Reports Results for the Second Quarter of 2020 and Closing of Nashville Land Sale
Dover Motorsports, Inc. (NYSE: DVD) today reported results for the three months ended June 30, 2020.
The COVID-19 pandemic caused the postponement of the Company’s scheduled May NASCAR weekend
Dover Motorsports, Inc. Announces Second Quarter 2020 Earnings Release Date
Dover Motorsports, Inc. (NYSE: DVD) will report its earnings for the second quarter ended June 30, 2020 on the morning of Thursday, July 30, 2020. Commentary from the Company’s executive officers
Dover International Speedway’s Aug. 21-23 NASCAR Weekend to Be Held Without Fans Due to COVID-19 Concerns
The Aug. 21-23 NASCAR weekend at Dover International Speedway will take place without fans due to concerns surrounding the coronavirus (COVID-19) pandemic.
While the six races at The Monster Mile
National Institutes of Health (NIH) Awards Research Grant of $2.59 Million to University of Pittsburgh for Diabetes Gene Therapy Technology Licensed by Genprex
Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today
Heat Biologics: Erste NBC-Empfehlung mit +1.375% in 5 Monaten
Mit Heat Biologics (WKN: A2JB4Y) kannte die erste Empfehlung des weltweit einzigartig erfolgreichen No Brainer Clubs zuletzt kein Halten mehr. Seit Ende Februar steht eine Kursperformance von
Amendments to ProtoKinetix AAGP® Protocol for Continuation of Phase 1 Human Trials by the University of Alberta Submitted to Health Canada
ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB: PKTX), a clinical-stage biomedical company, today announced an update to the Press Release of March 24,
ProtoKinetix AAGP® Dry Eye Program Advancing
ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB:PKTX), a clinical-stage biomedical company, provides the following update regarding upcoming news in its
Fuel Tech Awarded Multiple Equipment Orders Totaling $2.2 Million
Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering solutions for the optimization of combustion systems, emissions control and water treatment in utility and